Healthcare IT News May 11, 2020
Nathan Eddy

Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway and JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.

Atul Gawande, who in 2018 was appointed CEO of Haven, the nonprofit healthcare venture launched by the founders of Amazon, JP Morgan Chase & Co. and Berkshire Hathaway, is in “advanced discussions” to step down from the role, according to a Dow Jones report.

WHY IT MATTERS
Dr. Gawande, a surgeon and Harvard professor, was tapped to lead the then-unnamed joint venture nearly two years ago in 2018. Haven’s much-publicized debut positioned it as a disruptive force in the healthcare industry that would harness technology to lower costs...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Insurance, Payer, Self-insured
Related Articles:
Payer executives expect limited change in ACA subsidies
5 payer updates shaking up the ASC industry
Commercial, individual markets growing increasingly concentrated: 7 numbers to know
Remote Patient Monitoring Works … What are Payers and Providers Waiting for?
GAO finds private insurance market became increasingly concentrated last decade

Share This Article